Promising Gene Therapy Helps Reduce Transfusion In Patients With Blood Disorders People with beta-thalassemia, a genetic blood disorder, could benefit from a promising gene therapy. The therapy, LentiGlobin, is reported to reduce or eliminate the need for blood transfusions in patients enrolled in Phase 1 and 2 trials. by Rubi Valdez
Health Everything You Need To Know About The Blood Disorder Thalassemia: Signs, Symptoms, Treatment by Milafel Dacanay